Pliant Therapeutics, Inc. (PLRX) Misses Q1 EPS by 15c

Pliant Therapeutics, Inc. (NASDAQ: PLRX) reported Q1 EPS of ($0.92), $0.15 worse than the analyst estimate of ($0.77).

For earnings history and earnings-related data on Pliant Therapeutics, Inc. (PLRX) click here.

You May Also Be Interested In

• Electra Therapeutics files for proposed IPO
• AiRWA receives Nasdaq deficiency notice over late 10-K filing
• Nomura/Instinet Starts Clean Max Enviro Energy Solutions (CLEANMAX:IN) at Buy